Stockscreener 앱 받기
1.62
2.53%
0.04
시장 영업 전:
1.57
-0.05
-3.09%
Pacific Biosciences Of California Inc 주식(PACB)의 최신 뉴스
Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know - Yahoo! Finance Canada
Pacific Biosciences of California, Inc. (PACB) Stock Price, News, Quote & History - Yahoo! Finance Canada
How to build the scientific case that gets your grant funded - PacBio
PACB Stock Firms Up Ahead Of Morgan Stanley Healthcare Chat - StocksToTrade
Pacific Biosciences of California (PACB) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push - Yahoo Finance
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today - Yahoo Finance
CCORF Maintains Pacific Biosciences of California(PACB.US) With Buy Rating - Moomoo
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know - Yahoo Finance
How to build a more competitive grant proposal without losing your research time to it - PacBio
Pacific Biosciences Coverage Assumed by UBS at Neutral - Moomoo
Q2 Earnings Highlights: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks - The Globe and Mail
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue? - Eastern Progress
PacBio to Participate in the Morgan Stanley 24?? Annual Global Healthcare Conference - marketscreener.com
PACB stock gains as PacBio highlights sequencing strength ahead Morgan Stanley conference - ad-hoc-news.de
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference - marketscreener.com
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - TradingView
PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test - TradingView
3 Reasons to Sell PACB and 1 Stock to Buy Instead - Yahoo Finance
Pacific Biosciences (PACB) Tumbles 9.7% to $1.40, Nears Critical Support at $1.33Stock News - vinanet.vn
PACB Q2 2026 Earnings: Wider-than-Expected Per-Share Loss Drives 9.68% SelloffEstimate Uncertainty - careplusvn.com
Pacific (PACB) EPS and Revenue: EPS Misses Its Estimate in the Reported Period; Share Response: The Stock Loses 5.19% on the DayEarnings Preview - careplusvn.com
Pacific (PACB) Momentum: Ends Higher by 9.76% at $1.35 for the Current Session; Price Levels - careplusvn.com
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Pacific (PACB) Earnings Update: EPS Misses Its Estimate on the Day; Trading Response: Shares Close 11.40% Higher in Latest TradingEarnings Weakness Phase - Vinanet
Pacific Biosciences CEO Mark van Oene sells $30,409 in stock By Investing.com - Investing.com South Africa
Pacific Biosciences CEO Mark van Oene sells $30,409 in stock - Investing.com
Insider Selling: Pacific Biosciences of California (NASDAQ:PACB) Insider Sells 26,911 Shares of Stock - MarketBeat
PacBio (NASDAQ: PACB) CEO share sale covers RSU tax withholding - Stock Titan
Pacific Biosciences of California Inc (HAM:P09) Stock Price, Trades & News - GuruFocus
Pacific Biosciences of California Inc (PACB) (Q2 2026) Earnings - GuruFocus
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SEC Filing (Aug 17, 2026) - Stock Titan
PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity - MarketBeat
ARK reports 9.59% stake in Pacific Biosciences (PACB) - Stock Titan
5 Must-Read Analyst Questions From PacBio’s Q2 Earnings Call - Yahoo Finance
PACIFIC BIOSCIENCES (PACB) CEO granted 1.97M options and 489K RSUs - Stock Titan
Measuring – not guessing – the true path - PacBio
Weekly Recap: PACB cuts 2026 revenue guide and Mark Van Oene named CEO - TradingView
Pacific Biosciences of California, Inc. $PACB Shares Sold by Renaissance Technologies LLC - MarketBeat
Pacific Biosciences of California, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PACB) 2026-08-08 - Seeking Alpha
Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29 - simplywall.st
Pacific Biosciences of California (NASDAQ:PACB) Cut to "Sell" at Wall Street Zen - MarketBeat
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2026: Revenue $39.01M, EPS ($0.14) — 10-Q Summary - TradingView
Pacific Biosciences of California, Inc. Stock 12‑Month Price Target Cut to $2.29, Implies 76% Upside - TradingView
TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3 - Moomoo
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut - Yahoo Finance
Pacific Biosciences (PACB) Drops 6.5% to $1.22, Testing Key Support LevelSmart Money Flow Stocks - careplusvn.com
Pacific Biosciences: It's Only Getting Worse (NASDAQ:PACB) - Seeking Alpha
Pacific Biosciences of California Q2 Earnings Call Highlights - TradingView
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Pacific Biosciences of California Appoints New CEO, Plans to Cut 8% of Workforce - Moomoo
Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
1.51%
0.97%
자본화:
|
볼륨(24시간):